BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REGEND007 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of REGEND007\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07359963-1555@assetmemo.bio
DTSTAMP:20261121T004534Z
DTSTART;VALUE=DATE:20270215
DTEND;VALUE=DATE:20270216
SUMMARY:REGEND007: Phase 1 readout est. (NCT07359963)
DESCRIPTION:REGEND007\, phase 1.\nStudy: Treatment of Idiopathic Pulmonary 
 Fibrosis (IPF) by REGEND007 Cell Therapy\nEstimated primary completion: 15
  February 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/regen
 d007#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NC
 T07359963
URL:https://assetmemo.bio/drug/regend007#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
